nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2024, 04, v.43 376-381
帕金森病中医证候与嗅觉障碍相关性研究
基金项目(Foundation): 南京市医学科技发展项目重点项目(编号:ZKX20050);南京市医学科技发展项目一般项目(编号:YKK22173); 南京市中医药青年人才培养项目(编号:NJSZYYQNRC-2020); 蔡定芳南京市中医院岐黄学者工作站项目(编号:QHXZGZZ-2023-CDF)
邮箱(Email): tanglili-tll@126.com;
DOI: 10.16295/j.cnki.0257-358x.2024.04.009
摘要:

目的:探讨帕金森病(PD)患者中医证候与嗅觉障碍影响因素相关性。方法:2020年10月至2022年12月,随机纳入108例PD患者,采用SS-16测试、Hoehn-Yahr(H-Y)分期、蒙特利尔认知评估量表(MoCA)、新版世界运动障碍学会PD综合评价量表第三部分(MDS-UPDRSⅢ)等评估患者病情,以嗅觉测试结果分为嗅觉障碍组与嗅觉正常组。结果:PD患者嗅觉障碍发生率为65.7%,两组在年龄(P=0.006)、H-Y分期(P=0.012)、MoCA评分(P=0.016)、MDS-UPDRSⅢ评分(P=0.010)方面差异有统计学意义;二元Logistic回归分析提示嗅觉障碍与性别(OR=3.504,P=0.023)存在显著相关性。嗅觉障碍组与嗅觉正常组之间中医证候分布差异有统计学意义(P=0.017)。无序多分类Logistic回归分析提示,患者嗅觉障碍与否(OR=9.047,P=0.018)影响血瘀动风证与肝肾不足证两者诊断;MoCA评分(OR=1.146,P=0.046)影响患者气血两虚证与肝肾不足证两者诊断。结论:(1)嗅觉障碍组与嗅觉正常组中医证候存在差异;(2)嗅觉障碍有助于患者血瘀动风证与肝肾不足证两者的鉴别诊断。

Abstract:

Objective:To explore the correlation between traditional Chinese medicine(TCM) syndromes and dysosmia in patients with Parkinson's disease(PD). Methods:From October 2020 to December 2022 108patients with PD were included randomly. “Sniffin' Sticks” odor identification test(SS-16),Hoehn-Yahr(H-Y) staging,MoCA score,MDS-UPDRS Ⅲ were applied to evaluate patients. These patients were divided into normal olfactory group and dysosmia group according to the SS-16 test results. Results:The incidence of dysosmia in patients with PD was 65.7%. There were statistically significant differences in age(P=0.006),H-Y staging(P=0.012),Mo CA score(P=0.016) and MDS-UPDRS Ⅲ scores(P=0.010) between the two groups. Binary Logistic regression analysis indicated that there was a significant correlation between dysosmia and gender(OR=3.504,P=0.023). There was a significant difference in TCM syndrome distribution between the dysosmia group and the normal olfactory group(P=0.017). Disordered multiple logistic regression analysis suggested that the presence or absence of olfactory dysfunction in patients(OR=9.047,P=0.018) affects the diagnosis of blood stasis with wind stirring syndrome and liver and kidney deficiency syndrome;The Mo CA score(OR=1.146,P=0.046) affected the diagnosis of both qi and blood deficiency syndrome and liver and kidney deficiency syndrome in patients. Conclusions:There are differences in TCM syndromes between the dysosmia group and the olfactory normal group. The dysosmia affects the diagnosis of both blood stasis with wind stirring syndrome and liver and kidney deficiency syndrome in patients.

参考文献

[1]雒晓东,李哲,朱美玲,等.帕金森病(颤拘病)中医临床诊疗专家共识[J].中医杂志,2021,62(23):2109-2116.

[2]陈兴,邢峰博,刘婷婷,等.帕金森病患者嗅觉功能与认知功能和运动症状相关性分析[J].中国现代神经疾病杂志,2021,21(10):887-892.

[3] SOLLA P,MASALA C,ERCOLI T,et al. Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype:a pilot study[J]. Brain Sci,2022,12(2):196.

[4] BANG Y,LIM J,CHOI H J. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease:clues to early diagnosis and effective treatment[J]. Arch Pharmacal Res,2021,44(6):588-604.

[5]吴巧珍,王强.帕金森病嗅觉减退与非运动症状的相关性研究进展[J].中风与神经疾病杂志,2022,8(11):1052-1056.

[6]薛晓帆,肖燕,周立春,等.帕金森病前驱期非运动症状的相关研究进展[J].中风与神经疾病杂志,2021,38(9):797-800.

[7]李凌,王峰,卢镇泽,等.帕金森病嗅觉障碍辅助诊断卡对帕金森病患者嗅觉功能的评估作用[J].中国现代神经疾病杂志,2022,22(3):163-167.

[8]蔡谋善,吴琼,陈凤仪.帕金森病患者的嗅觉功能、嗅球体积、嗅沟深度变化及诊断价值[J].临床和实验医学杂志,2019,5(3):293-295.

[9] BLOEM B R,OKUN M S,KLEIN C. Parkinson’s disease[J]. Lancet,2021,397(10291):2284-2303.

[10]史鑫鑫,何建成,符德玉,等.从“风、血、毒”探讨帕金森病的病机与治疗[J].中华中医药学刊,2022,40(3):121-124.

[11]李元,王顺,白妍,等.帕金森病药源性异动症的中医治疗研究进展[J].辽宁中医药大学学报,2023,25(4):68-72.

[12]张怡,唐莉莉,赵杨.赵杨治疗中晚期帕金森病临床经验[J].中医药临床杂志,2021,33(11):2094-2097.

[13]李雨濛.帕金森病嗅觉障碍患者中医证候要素特征研究[D].北京:北京中医药大学,2015.

[14]李葭荣.帕金森病嗅觉功能与中医证候要素相关性调查[D].合肥:安徽中医药大学,2019.

[15]王茜.帕金森病运动症状的中医证候要素特征研究[D].南京:南京中医药大学,2020.

[16]中医老年颤证诊断和疗效评定标准(试行)[J].山东中医学院学报,1992,16(6):55.

[17]张月琪,王刚.国际运动障碍疾病协会帕金森病临床诊断新标准(2015)介绍[J].诊断学理论与实践,2016,15(2):122-123.

[18] MARTINEZ-MARTIN P,RODRIGUEZ-BLAZQUEZ C,MARIO A,et al. Parkinson’s disease severity levels and MDS-Unified Parkinson’s Disease Rating Scale[J]. Parkinsonism Relat Disord,2015,21(1):50-54.

[19] TEMPLETON J M,POELLABAUER C,SCHNEIDER S. Towards symptom-specific intervention recommendation systems[J]. J Parkinsons Dis,2022,12(5):1621-1631.

[20] CHEN W,CHEN S,KANG W Y,et al. Application of odor identification test in Parkinson’s disease in China:a matched case-control study[J]. J Neurol Sci,2012,316(1-2):47-50.

[21]杨改清,吴孟娇,祁萌萌,等. P300联合MoCA对帕金森病患者认知功能障碍的诊断价值[J].中国老年学杂志,2021,41(15):3244-3246.

[22]胡艳峰,孙玉信.从脏腑辨治嗅觉障碍[J].中医杂志,2021,62(13):1175-1178.

[23]张月美,汪瀚.从五脏认识帕金森病嗅觉障碍[J].中医药临床杂志,2023,35(1):9-12.

[24] DAN X,WECHTER N,GRAY S,et al. Olfactory dysfunction in aging and neurodegenerative diseases[J].Ageing Res Rev,2021,70:101416.

[25] NIGRO P,CHIAPPINIELLO A,SIMONI S,et al. Changes of olfactory tract in Parkinson’s disease:a DTI tractography study[J]. Neuroradiology,2021,63(2):235-242.

[26] MENELAOU G,PERSSON J,OLOFSSON J K. Hippocampal subfield volumes and olfactory performance:emerging longitudinal associations over a 5-year interval[J]. Neuropsychologia,2022,176:108353.

[27] CAVACO S,GON?ALVES A,MENDES A,et al. Abnormal olfaction in Parkinson’s disease is related to faster disease progression[J]. Behav Neurol,2015,2015:976589.

[28]黄悦,翟志远,郑金龙,等.帕金森病嗅觉障碍与认知功能关系的Meta分析[J].中国临床研究,2022,35(8):1088-1094.

[29]汤海燕,谈鹰,冯颖,等.帕金森病患者嗅觉减退的临床特点及影响因素分析[J].浙江医学,2021,43(3):290-293.

[30]林懿祺.帕金森病认知减退与嗅觉障碍的相关性研究[D].上海:上海交通大学,2019.

[31]刘香丹,田玉玲,司海娜.帕金森病患者嗅觉障碍及其相关因素分析[J].中国神经免疫学和神经病学杂志,2019,26(3):196-200.

[32]肖一峰,吴婧.帕金森病嗅觉障碍研究进展[J].中国实用神经疾病杂志,2020,23(16):1466-1472.

[33]马俊保,孙丽萍,姬要可,等.帕金森病患者嗅觉减退的危险因素分析[J].中国实用神经疾病杂志,2017,20(9):81-83.

[34] WITT M,BORMANN K,GUDZIOL V,et al. Biopsies of olfactory epithelium in patients with Parkinson’s disease[J]. Mov Disord,2009,24(6):906-914.

[35]刘建宪,甘洁,姬琳.早期帕金森病合并嗅觉功能障碍的静息态fMRI研究[J].中国中西医结合影像学杂志,2020,18(4):342-346.

[36]任基刚,杨丽铭,田斌,等.帕金森病伴认知障碍患者的嗅觉脑区灰质形态学改变[J].临床放射学杂志,2021,40(12):2255-2260.

[37]费露,刘美琪,朱其风,等.磁敏感加权成像在帕金森病和多系统萎缩的诊断及鉴别诊断中的应用研究[J].中国临床神经科学,2022,30(4):407-413.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2024.04.009

中图分类号:R277.7

引用信息:

[1]杨黎明,唐莉莉.帕金森病中医证候与嗅觉障碍相关性研究[J].山东中医杂志,2024,43(04):376-381.DOI:10.16295/j.cnki.0257-358x.2024.04.009.

基金信息:

南京市医学科技发展项目重点项目(编号:ZKX20050);南京市医学科技发展项目一般项目(编号:YKK22173); 南京市中医药青年人才培养项目(编号:NJSZYYQNRC-2020); 蔡定芳南京市中医院岐黄学者工作站项目(编号:QHXZGZZ-2023-CDF)

投稿时间:

2023-10-27

投稿日期(年):

2023

终审时间:

2024-01-15

终审日期(年):

2024

修回时间:

2024-01-18

审稿周期(年):

1

发布时间:

2024-04-05

出版时间:

2024-04-05

检 索 高级检索